首页|期刊导航|中国药理学与毒理学杂志|小檗碱通过修复MAMs结构调控钙信号通路改善CUMS大鼠抑郁样行为

小檗碱通过修复MAMs结构调控钙信号通路改善CUMS大鼠抑郁样行为OA

Berberine improves depression-like behavior in CUMS rats by modulating MAMs structure and calcium signaling

中文摘要英文摘要

目的 探讨小檗碱改善慢性不可预知温和应激(CUMS)大鼠抑郁样行为的作用机制.方法 ① 小檗碱表征:采用扫描电镜、紫外-可见光谱、傅里叶变换红外光谱、荧光光谱及核磁共振氢谱等技术表征小檗碱的物理化学特性.② 体内实验:将大鼠随机分为对照组、模型组、模型+舍曲林5.25 mg·kg-1组和模型+小檗碱50 mg·kg-1组,采用CUMS法构建抑郁大鼠模型,在造模期间,各给药组每日ig给药1次,连续4周,对照组和模型组给予等体积生理盐水.造模开始前(第0天)和造模结束时(第28天)称量大鼠体重.糖水偏好实验检测糖水偏好率;强迫游泳实验检测不动时间;旷场实验检测大鼠首次离开中央区域的潜伏期、穿越格数和站立次数;Morris水迷宫实验检测逃避潜伏期和穿越平台次数;小肠推进实验检测小肠推进率;HE染色和Nissl染色观察海马神经元损伤情况;通过转录组测序筛选小檗碱抗抑郁的关键信号通路.③ 体外实验:建立皮质酮(CORT)诱导的大鼠肾上腺嗜铬细胞瘤细胞(PC12)损伤模型,将PC12细胞分为对照组、CORT 400 μmol·L-1组和CORT+小檗碱40 μmol·L-1组,透射电镜观察MAMs超微结构;采用Rhod-2 AM和DCFH-DA荧光探针分别检测线粒体钙离子和活性氧(ROS)水平;采用免疫荧光染色检测线粒体钙单向转运体(MCU)荧光强度,以及1,4,5-三磷酸肌醇受体1型(IP3R1)与电压依赖性阴离子通道1(VDAC1)蛋白的共定位情况.结果 ① 小檗碱具有典型针状结晶形态与特征光谱,分子结构明确、特征典型,可用于后续体内外实验.② 与对照组相比,模型组大鼠体重增量显著减小,糖水偏好率明显下降,强迫游泳不动时间显著延长,旷场实验中首次离开中央区域的潜伏期显著增加、穿越格数与站立次数显著减少,Morris水迷宫逃避潜伏期显著延长、穿越平台次数显著减少,小肠推进率显著降低;HE与Nissl染色显示模型组海马神经元排列松散,核固缩现象明显,尼氏体数量显著减少.与模型组相比,小檗碱干预后大鼠的体重增量显著增加,糖水偏好率显著升高,强迫游泳不动时间明显缩短,旷场实验的首次离开中央区域的潜伏期显著缩短、穿越格数与站立次数显著增加,Morris水迷宫逃避潜伏期显著缩短、穿越平台次数显著增加;小肠推进率显著提高;HE染色与Nissl染色显示,海马神经元排列紧密,细胞间隙减小,核固缩现象减轻、尼氏体数量显著增加;转录组测序分析表明,钙信号通路是其发挥抗抑郁效应的关键调控通路.③ 与CORT组相比,CORT+小檗碱组MAMs接触面积显著减少,线粒体钙离子荧光强度和ROS荧光强度显著降低,MCU荧光强度显著降低,IP3R1/VDAC1的异常共定位显著减少.结论 小檗碱通过修复MAMs结构和调控钙信号通路,改善CUMS大鼠抑郁样行为.

OBJECTIVE To investigate whether berberine ameliorates depression-like behavior in chronic unpredictable mild stress(CUMS)rats by restoring the structure of mitochondria-associated endoplasmic reticulum membranes(MAMs)and regulating the calcium signaling pathway.METHODS The physicochemical properties of berberine were characterized by scanning electron microscopy,ultraviolet-visible spectroscopy,Fourier transform infrared spectroscopy,fluorescence spectroscopy and nuclear magnetic resonance spectroscopy.The in vivo antidepressant effect of berberine was evaluated using a CUMS rat model.Rats were randomly assigned to four groups:a control group,model group,model+sertraline 5.25 mg·kg-1 group,and model+berberine 50 mg·kg-1 group.The treatment groups received daily intragastric administration for 4 consecutive weeks while the control and model groups received an equal volume of normal saline.The body mass of the rats was measured before the experiment(day 0)and at the end of the experiment(day 28).Depression-like behavior was assessed using the sucrose preference rate and immobility time in the forced swimming test.Anxiety-like behavior and locomotor activity were evaluated by residence time in the central area,number of crossing,and number of rearing in the open field test.Spatial learning and memory ability were assessed via escape latency and the number of platform crossing in the Morris water maze test.Meanwhile,the small intestinal propul-sion rate was measured to evaluate gastrointestinal motility.HE staining and Nissl staining were performed to observe hippocampal neuronal damage.RNA sequencing was performed to screen the key signaling pathways regulated by berberine.An in vitro injury model was established using corticosterone(CORT)-induced rat adrenal pheochromocytoma cell line(PC12)that were divided into a control group,CORT 400 μmol·L-1 group and CORT+berberine 40 μmol·L-1 group.Transmission electron microscopy was used to observe MAMs ultrastructure.Mitochondrial calcium and reactive oxygen species(ROS)levels were detected using Rhod-2 AM and DCFH-DA fluorescent probes,respectively.The fluo-rescence intensity of the mitochondrial calcium uniporter(MCU)and the co-localization of inositol 1,4,5-trisphosphate receptor type 1(IP3R1)and voltage-dependent anion channel 1(VDAC1)proteins were detected by immunofluorescence staining.RESULTS The results of physical and chemical character-ization confirmed that berberine had typical needle-like crystal morphology and characteristic spectrum,clear molecular structure and typical properties,which could be used for subsequent in vivo and in vitro experiments.The in vivo results showed that,compared with the control group,the mass gain of rats in the model group was significantly reduced,the sucrose preference rate was significantly decreased,the immobility time of forced swimming was significantly prolonged,the latency to leave the central area of the open field was significantly increased,the number of crossing and rearing was significantly reduced,the escape latency of Morris water maze was significantly prolonged,the number of platform crossing was significantly reduced,and the intestinal propulsion rate was significantly lowered.HE and Nissl staining showed that hippocampal neurons in the model group were loosely arranged,nuclear condensation was obvious,and the number of Nissl bodies was significantly decreased.Compared with the model group,berberine intervention significantly increased mass gain and the sucrose preference rate,significantly shortened the immobility time in the forced swimming test,shortened the latency to leave the central area,increased the number of crossing and rearing in the open field test,shortened the escape latency and increased the number of platform crossing in the Morris water maze test,and significantly elevated the small intestinal propulsion rate.HE and Nissl stain-ing of the hippocampus showed densely arranged neurons,reduced intercellular spaces,decreased pyknotic nuclei,and markedly increased Nissl bodies.Transcriptome sequencing analysis found that the calcium signaling pathway was a key regulatory pathway for its antidepressant efficacy.The in vitro results showed that berberine effectively repaired CORT-induced MAMs ultrastructural damage in PC12 cells,significantly inhibited mitochondrial calcium overload and oxidative stress,reduced MCU fluorescence intensity,and decreased the abnormal co-localization of IP3R1/VDAC1.CONCLUSION Berberine can significantly improve the depression-like behavior of CUMS rats by repairing MAMs structure and regulating the calcium signaling pathway.

张子童;李威衡;田佳雪;王彤;孙乐华;秦雪梅;刘晓节

山西大学中医药现代研究中心,山西 太原 030006山西大学中医药现代研究中心,山西 太原 030006山西大学中医药现代研究中心,山西 太原 030006山西大学中医药现代研究中心,山西 太原 030006山西大学中医药现代研究中心,山西 太原 030006山西大学中医药现代研究中心,山西 太原 030006山西大学中医药现代研究中心,山西 太原 030006||山西大学经方扶阳山西省重点实验室,山西 太原 030006

医药卫生

小檗碱抗抑郁线粒体相关内质网膜钙信号通路线粒体钙单向转运体慢性不可预知温和应激

berberineantidepressantmitochondria-associated endoplasmic reticulum membranescalcium signaling pathwaymitochondrial calcium uniporterchronic unpredictable mild stress

《中国药理学与毒理学杂志》 2026 (8)

593-605,13

经方扶阳山西省重点实验室开放课题研究基金项目(202504010932053)山西省中医药管理局资助项目(2024ZYY2A032)山西省中医药创新团队(zyytd2024020) The Shanxi Key Laboratory of Classic Prescription Yang-Strengthening(202504010932053)the Ad-ministration of Traditional Chinese Medicine of Shanxi Province(2024ZYY2A032)and the Traditional Chinese Medi-cine Innovation Team of Shanxi Province(zyytd2024020)

10.3867/j.issn.1000-3002.2026.08935

评论